I am a
Home I AM A Search Login

Papers of the Week


2023 Jan 03


Handb Exp Pharmacol

CACNA1A-Related Channelopathies: Clinical Manifestations and Treatment Options.

Authors

Indelicato E, Boesch S
Handb Exp Pharmacol. 2023 Jan 03.
PMID: 36592223.

Abstract

In the last decade, variants in the Ca channel gene CACNA1A emerged as a frequent aetiology of rare neurological phenotypes sharing a common denominator of variable paroxysmal manifestations and chronic cerebellar dysfunction. The spectrum of paroxysmal manifestations encompasses migraine with hemiplegic aura, episodic ataxia, epilepsy and paroxysmal non-epileptic movement disorders. Additional chronic neurological symptoms range from severe developmental phenotypes in early-onset cases to neurobehavioural disorders and chronic cerebellar ataxia in older children and adults.In the present review we systematically approach the clinical manifestations of CACNA1A variants, delineate genotype-phenotype correlations and elaborate on the emerging concept of an age-dependent phenotypic spectrum in CACNA1A disease. We furthermore reflect on different therapy options available for paroxysmal symptoms in CACNA1A and address open issues to prioritize in the future clinical research.